Cargando…

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses

Influenza viruses collected from regions of Asia, Africa and Oceania between 2009 and 2012 were tested for their susceptibility to two new neuraminidase inhibitors, peramivir and laninamivir. All viruses tested had normal laninamivir inhibition. However, 3·2% (19/599) of A(H1N1)pdm09 viruses had hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leang, Sook-Kwan, Kwok, Simon, Sullivan, Sheena G, Maurer-Stroh, Sebastian, Kelso, Anne, Barr, Ian G, Hurt, Aeron C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Short Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186459/ https://www.ncbi.nlm.nih.gov/pubmed/24734292 http://dx.doi.org/10.1111/irv.12187

Ejemplares similares

Detection of Peramivir and Laninamivir, New Anti-Influenza Drugs, in Sewage Effluent and River Waters in Japan
por: Azuma, Takashi, et al.
Publicado: (2015)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Mutations I117V and I117M and Oseltamivir Sensitivity of Pandemic (H1N1) 2009 Viruses
por: Hurt, Aeron C., et al.
Publicado: (2012)

Peramivir for influenza
Publicado: (2019)

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact
por: Oh, Ding Yuan, et al.
Publicado: (2014)

Progressive emergence of an oseltamivir‐resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient
por: Hurt, Aeron C., et al.
Publicado: (2013)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Safety and efficacy of peramivir for influenza treatment
por: Hata, Atsuko, et al.
Publicado: (2014)

Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
por: Mizuno, Takuro, et al.
Publicado: (2014)

Detection of Evolutionarily Distinct Avian Influenza A Viruses in Antarctica
por: Hurt, Aeron C., et al.
Publicado: (2014)

Performance of influenza rapid point‐of‐care tests in the detection of swine lineage A(H1N1) influenza viruses
por: Hurt, Aeron C., et al.
Publicado: (2009)

Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility
por: Farrukee, Rubaiyea, et al.
Publicado: (2020)

A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions
por: Koszalka, Paulina, et al.
Publicado: (2020)

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
por: Kashiwagi, Seizaburo, et al.
Publicado: (2016)

Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?
por: Hurt, Aeron, et al.
Publicado: (2017)

Peramivir injection in the treatment of acute influenza: a review of the literature
por: Wester, Ashley, et al.
Publicado: (2016)

Infection with different human influenza A subtypes affects the period of susceptibility to secondary bacterial infections in ferrets
por: Mifsud, Edin J, et al.
Publicado: (2022)

Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model
por: Guarnaccia, Teagan, et al.
Publicado: (2013)

Pregnancy outcomes of women exposed to laninamivir during pregnancy
por: Minakami, Hisanori, et al.
Publicado: (2014)

Laninamivir-induced ischemic enterocolitis: A case report
por: Suzuki, Chihiro, et al.
Publicado: (2022)

Single‐dose inhaled laninamivir: registered in Japan and its potential role in control of influenza epidemics
por: Sunagawa, Satoko, et al.
Publicado: (2012)

Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza
por: Vanchiere, John, et al.
Publicado: (2017)

A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade
por: Oh, Ding Yuan, et al.
Publicado: (2014)

Adult influenza A (H3N2) with reduced susceptibility to baloxavir or peramivir cured after switching anti-influenza agents
por: Seki, Masafumi, et al.
Publicado: (2019)

Impact of a large deletion in the neuraminidase protein identified in a laninamivir‐selected influenza A/Brisbane/10/2007 (H3N2) variant on viral fitness in vitro and in ferrets
por: Ann, Julie, et al.
Publicado: (2016)

Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution
por: Farrukee, Rubaiyea, et al.
Publicado: (2022)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
por: Gubareva, Larisa V., et al.
Publicado: (2017)

Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
por: Hikita, Toshiyuki, et al.
Publicado: (2012)

Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
por: Alame, Malak M., et al.
Publicado: (2016)

A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir
por: Baik, Seung Hee, et al.
Publicado: (2015)

Clinical Effectiveness and Safety of Peramivir for Influenza Infection: Safe and Effective Antiviral Treatment
por: Lee, Jin Seo
Publicado: (2018)

Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2017)

Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients
por: Lee, Jin Seo, et al.
Publicado: (2020)

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influenza in Chickens
por: Twabela, Augustin, et al.
Publicado: (2020)

A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity
por: Oh, Ding Yuan, et al.
Publicado: (2015)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
por: Takashita, Emi, et al.
Publicado: (2015)

Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition
por: Vavricka, Christopher J., et al.
Publicado: (2011)

Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects
por: Zhang, Chen-xi, et al.
Publicado: (2022)

Antiviral Therapy for the Next Influenza Pandemic
por: Hurt, Aeron C.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4njl1esv98n8effo353ouj9m95